Fred Alger Management, LLC Cabaletta Bio, Inc. Transaction History
Fred Alger Management, LLC
- $20.2 Billion
- Q2 2025
A detailed history of Fred Alger Management, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 59,813 shares of CABA stock, worth $79,551. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,813
Previous 477,210
87.47%
Holding current value
$79,551
Previous $663,000
86.43%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CABA
# of Institutions
88Shares Held
74.5MCall Options Held
327KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$12.9 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$11.7 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$9.04 Million0.01% of portfolio
-
Jennison Associates LLC6.02MShares$8.01 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$6.65 Million0.77% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $38.6M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...